We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | NYSE:JNJ | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -1.34 | -0.89% | 149.84 | 152.33 | 149.14 | 151.77 | 8,578,079 | 23:01:51 |
From May 2019 to May 2024
Johnson & Johnson (JNJ) is nearing a deal to buy Pharmacyclics Inc. (PCYC), a developer of cancer treatments, the Financial Times reported Wednesday on its website, citing people familiar with the matter.
A deal could be reached in the coming days, although talks could still fall apart, the people told the FT.
Last month Bloomberg News, citing people with knowledge of the matter, reported that J&J and Novartis AG (NVS) had shown interest in buying Pharmacyclics.
Web site: www.ft.com
Write to nymonitoring@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Johnson and Johnson Chart |
1 Month Johnson and Johnson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
